Phospho-TrkA (Tyr674/675)/TrkB (Tyr706/707) Antibody [K13K11]

카탈로그 번호 F0403

인쇄

생물학적 설명

특이성 Phospho-TrkA (Tyr674/675)/TrkB (Tyr706/707) Antibody [K13K11]는 내인성 TrkA 총량의 Tyr674/675 인산화 상태와 TrkB 단백질의 Tyr706/707 인산화 상태만을 각각 검출합니다.
배경 Phospho-TrkA (Tyr674/675)/TrkB (Tyr706/707)는 TrkA (NTRK1) 및 TrkB (NTRK2)의 키나제 도메인에 있는 자가인산화된 활성화 루프 티로신을 지칭하며, 이들은 TrkC를 포함하는 신경영양 Trk receptor 계열의 구성원입니다. 이들은 TrkA의 경우 NGF, TrkB의 경우 BDNF/NT4와 같은 특정 리간드에 의해 활성화되어 신경 세포 생존 및 발달을 촉진합니다. 이 부위들은 촉매 키나제 도메인의 활성화 루프 내에 존재하며, 여기서 Tyr674/675 (TrkA) 또는 Tyr706/707 (TrkB)에서의 이중 인산화는 가족 구성원 전반에 걸쳐 보존되어 있으며, 기질 접근 및 트랜스-자가인산화를 촉진하여 활성 형태를 안정화시킵니다. 이는 종종 막횡단 및 막근접 영역을 포함하는 리간드 유도 이합체화에 의해 촉발됩니다. 이 부위들의 인산화는 완전한 키나제 활성화를 나타내며, Ras-MAPK/ERK와 같은 신호 전달 캐스케이드를 통해 증식/분화, PLCγ를 통한 신경돌기 성장, PI3K/Akt를 통한 생존을 가능하게 합니다. 반면, 돌연변이 또는 과발현은 리간드 비의존적 활성화를 유발하여 신경모세포종, 유방암 및 기타 암에서 종양 형성(oncogenesis)을 촉진합니다. 질병 상황에서, 비정상적인 Phospho-TrkA/B 수준은 자가분비 루프 및 아폽토시스 저항을 통해 종양에서 불량한 예후와 관련이 있습니다.

사용 정보

응용 WB, IP 희석
WB IP
1:1000 1:50
반응성 Human, Rat
출처 Rabbit Monoclonal Antibody MW 140 kDa
보관 완충액 PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
보관
(수령일로부터)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 5%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 120 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution ( recommending 5% BSA solution) for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

참조

  • https://pubmed.ncbi.nlm.nih.gov/8106527/
  • https://pubmed.ncbi.nlm.nih.gov/9099755/

적용 데이터

WB

Selleck 검증

  • F0403-wb
    Lane 1: NIH/3T3 (transfected with TrkA), Lane 2: NIH/3T3 (transfected with TrkA; NGF-treated), Lane 3: NIH/3T3 (transfected with TrkB), Lane 4: NIH/3T3 (transfected with TrkB; BDNF-treated)